Prospects for recombinant vaccines against Babesia bovis and related parasites

Parasite Immunology

Volumn 28, Issue 7, 2006, Pages 315-327

  Brown, W C ^a   Norimine, J ^a   Goff, W L ^a   Suarez, C E ^a   McElwain, T F ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Babesia bigemina; Babesia bovis; Babesia divergens; Babesiosis; Cattle; Vaccine antigens

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; PARASITE ANTIGEN; PROFILIN; PROTEIN 11C5; PROTEIN 12D3; PROTEIN ACS1; PROTEIN AMA 1; PROTEIN BD37; PROTEIN GP45; PROTEIN GP55; PROTEIN MSA 1; PROTEIN MSA 2A1; PROTEIN MSA 2A2; PROTEIN MSA 2B; PROTEIN MSA 2C; PROTEIN P0; PROTEIN RAP 1A; PROTEIN TRAP; PROTEIN VESA1; RECOMBINANT VACCINE; RHOPTRY ASSOCIATED PROTEIN 1; SPHERICAL BODY PROTEIN 1; SPHERICAL BODY PROTEIN 2; SPHERICAL BODY PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BABESIA BIGEMINA; BABESIA BOVIS; BABESIA DIVERGENS; CATTLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; GENOME ANALYSIS; HOST PARASITE INTERACTION; IMMUNE RESPONSE; IMMUNOREGULATION; INTERFERON PRODUCTION; MEMORY T LYMPHOCYTE; MORBIDITY; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE IMMUNITY; PARASITE SURVIVAL; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIGENS, PROTOZOAN; BABESIA BOVIS; BABESIOSIS; CATTLE; CATTLE DISEASES; DISEASE MODELS, ANIMAL; MICE; PROTOZOAN VACCINES; VACCINES, SYNTHETIC;

BABESIA; BABESIA BIGEMINA; BABESIA BOVIS; BABESIA DIVERGENS; BOS TAURUS;

EID: 33745646305     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2006.00849.x     Document Type: Review

References (120)

1. Kjemtrup AM & Conrad PA. Human babesiosis: an emerging tick-borne disease. Int J Parasitol 2000; 30: 1323-1337.
2. Criado-Fornelia A, Martinez-Marcos A, Buling-Saraña A & Barba-Carretero JC. Molecular studies on Babesia, Theileria, and Hepatozoon in southern Europe. Part II. Phylogenetic analysis and evolutionary history. Vet Parasitol 2004; 114: 173-194.
3. Wright IG & Goodger BV. Pathogenesis of babesiosis. In Babesiosis of Domestic Animals and Man, ed. Ristic M. Boca Raton: CRC Press; 1988: 99-118.
4. Clark IA & Jacobsen LS. Do babesiosis and malaria share a common disease process? Ann Trop Med Parasitol 1998; 92: 483-488.
5. Wright IG, Goodger BV & Clark IA. Immunopathophysiology of Babesia bovis and Plasmodium falciparum infections. Parasitol Today 1988; 4: 214-218.
6. Hemmer RM, Ferrick DA & Conrad PA. Role of T cells and cytokines in fatal and resolving experimental babesiosis: protection in TNFRp55-/- mice infected with the human Babesia WA1 parasite. J Parasitol 2000; 86: 736-742.
7. Zintl A, Mulcahy G, Skerrett HE, Taylor SM & Gray JS. Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin Micro Rev 2003; 16: 622-636.
8. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420: 502-507.
9. De Vos A & Bock RE. Vaccination against bovine babesiosis. Ann N Y Acad Sci 2000; 916: 540-545.
10. Dagliesh RJ. Babesiosis. In Immunology and Molecular Biology of Parasitic Infections, ed. Warren KS. Oxford: Blackwell; 1993: 352-383.
11. Davies SFM, Joyner LP & Kendall SB. Studies on Babesia divergens (M'Fadyean & Stockman, 1911). Ann Trop Med Parasitol 1958; 52: 206-215.
12. Wright IG, Casu R, Commins MA et al. The development of a recombinant Babesia vaccine. Vet Parasitol 1992; 44: 3-13.
13. Mahoney DF. Studies on the protection of cattle against Babesia bovis infection. In The Ruminant Immune System in Health and Disease, ed. Morrison WI. Cambridge: Cambridge University Press; 1986: 539-545.
14. Edelhofer R, Kanout A, Schuh M & Kutzer E. Improved disease resistance after Babesia divergens vaccination. Parasitol Res 1998; 84: 181-187.
15. Goff WL, Johnson CC & Cluff CW. Babesia bovis immunity. In vitro and in vivo evidence for IL-10 regulation of IFN-γ and iNOS. Ann NY Acad Sci 1998; 849: 161-180.
16. Brown WC & Palmer GH. Designing blood stage-vaccines against Babesia bovis and B. bigemina. Parasitol Today 1999; 15: 275-281.
17. Brown WC. Molecular approaches to elucidating innate and acquired immune responses to the protozoan parasite Babesia bovis that causes persistent infection. Vet Parasitol 2001; 101: 233-248.
18. Homer MJ, Aguilar-Delfin I, Telford SR III, Krause PJ, Persing DH. Babesiosis. Clin Microbiol Rev 2000; 13: 451-469.
19. Ruebush MJ & Hanson WL. Transfer of immunity to Babesia microti of human origin using T lymphocytes in mice. Cell Immunol 1980; 52: 255-265.
20. + T cells and gamma interferon in protective immunity against Babesia microti infection in mice. Infect Immun 1999; 67: 4143-4148.
21. Clawson ML, Paciorkowski N, Rajan TV et al. Cellular immunity, but not gamma interferon, is essential for resolution of Babesia microti infection in Balb/c mice. Infect Immun 2002; 70: 5304-5306.
22. Cavacini LA, Parke LA & Weidanz WP. Resolution of acute malaria infections by T cell-dependent non-antibody-mediated mechanisms of immunity. Infect Immun 1990; 58: 2946-2950.
23. Chen D, Copeman DB, Hutchinson GW & Burnell J. Inhibition of growth of cultured Babesia microti by serum and macrophages in the presence and absence of T cells. Parasite Immunol 2000; 22: 81-88.
24. Quick RE, Herwaldt BL, Thomford JW et al. Babesiosis in Washington State: a new species of Babesia? Ann Int Med 1993; 119: 284-290.
25. Aguilar-Delfin I, Homer MJ, Wettstein PJ & Persing DH. Innate resistance to Babesia infection is influenced by genetic background and gender. Infect Immun 2001; 69: 7955-7958.
26. East IJ, Zakrzewski H, Gale KR et al. Vaccination against Babesia bovis: T cells from protected and unprotected animals show different cytokine profiles. Int J Parasitol 1997; 27: 1537-1545.
27. Trueman KF & Blight GW. The effect of age on resistance of cattle to Babesia bovis. Aust Vet J 1978; 54: 301-305.
28. Goff WL, Johnson WC, Parish SM, Barrington GM, Tuo W & Valdez RA. The age-related immunity in cattle to Babesia bovis infection involves the rapid induction of interleukin-12, interferon-γ, and inducible nitric oxide synthase mRNA expression in the spleen. Parasite Immunol 2001; 23: 463-471.
29. Joyner LP & Donnelly J. The epidemiology of babesial infections. In Advances in Parasitology, eds Lumsden WHR, Muller R, Baker JR. London: Academic Press; 1979; 17: 115-140.
30. Christensson DA. Inverse age resistance to experimental Babesia divergens infection in cattle. Acta Vet Scand 1989; 30: 453-464.
31. Goff WL, Johnson WC, Horn RH, Barrington GM & Knowles DP. The innate immune response in calves to Boophilus microplus tick transmitted Babesia bovis involves type-1 cytokine induction and NK-like cells in the spleen. Parasite Immunol 2003; 25: 185-188.
32. Johnson WC, Cluff CW, Goff WL, Wyatt CR. Reactive oxygen and nitrogen intermediates and products from polyamine degradation are babesiacidal in vitro. Ann NY Acad Sci 1996; 791: 136-147.
33. Stich RW, Shoda LKM, Dreewes M, Adler B, Jungi TW & Brown WC. Stimulation of nitric oxide production by Babesia bovis. Infect Immun 1998; 66: 4130-4136.
34. Shoda LKM, Palmer GH, Florin-Christensen J, Florin-Christensen M, Godson DL & Brown WC. Babesia bovis-stimulated macrophages express interleukin-1β, interleukin-12, tumor necrosis factor-alpha, and nitric oxide, and inhibit parasite replication in vitro. Infect Immun 2000; 68: 5139-5145.
35. Goff WL, Storset AK, Johnson WC & Brown WC. Bovine splenic NK cells synthesize IFN-γ in response to IL-12 containing supernatants from Babesia bovis-exposed monocyte cultures. Parasite Immunol 2006; 28: 221-228.
36. Brown WC, Norimine J, Knowles DP & Goff WL. Immune control of Babesia bovis infection. Vet Parasitol 2006; 138: 75-87.
37. Medzhitov R & Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science 2002; 296: 298-300.
38. Iwasaki A & Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987-995.
39. Takeda K & Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17: 1-14.
40. + T regulatory cell function. Science 2005; 309: 1380-1384.
41. Yarovinski F, Zhang D, Andersen JF et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005; 308: 1626-1629.
42. Brown WC, Estes DM, Chantler SE, Kegerreis KA & Suarez CE. DNA and a CpG oligonucleotide derived from Babesia bovis are mitogenic for B cells. Infect Immun 1998; 66: 5423-5432.
43. Shoda LKM, Kegerreis KA, Suarez CE et al. DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor-alpha, and nitric oxide. Infect Immun 2001; 69: 2162-2171.
44. Werling D, Hope JC, Howard CJ & Jungi TW. Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists. Immunology 2004; 111: 41-52.
45. Zhang D, Zhang G, Hayden MS et al. A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303: 1522-1526.
46. Lauw FN, Caffrey DR & Golenbock DT. Of mice and man: TLR11 (finally) finds profilin. Trends Immunol 2005; 26: 509-511.
47. Allred DR & Al-Khedery B. Antigenic variation and cytoadhesion in Babesia bovis and Plasmodium falciparum: different logics achieve the same goal. Mol Biochem Parasitol 2004; 134: 27-35.
48. Brown WC & Logan KS. Babesia bovis: Bovine helper T cell lines reactive with soluble and membrane antigens of merozoites. Exp Parasitol 1992; 74: 188-199.
49. + T helper lymphocyte responses against Babesia bigemina rhoptry-associated protein-1. Infect Immun 1996; 64: 2079-2087.
50. + T cell clones activated in vitro. Infect Immun 1993; 61: 3273-3281.
51. + T-lymphocyte clones specific for rhoptry associated protein-1 (RAP-1) of Babesia bigemina stimulate enhanced immunoglobulin G1 (IgG1) and IgG2 synthesis. Infect Immun 1999; 67: 155-164.
52. 2 production from bovine B cells costimulated with anti-μ and mitogen. Cell Immunol 1994; 154: 287-295.
53. McGuire TC, Musoke AJ & Kurtii T. Functional properties of bovine IgG1 and IgG2: interaction with complement, macrophages, neutrophils, and skin. Immunology 1979; 38: 249-256.
54. Gallimore A, Dumrese T, Hengartner H, Zinkernagel RM & Rammensee HG. Protective immunity does not correlate with the hierarchy of virus- specific cytotoxic T cell responses to naturally processed peptides. J Exp Med 1998; 187: 1647-1657.
55. Gallimore A, Hombach J, Dumrese T, Rammensee HG, Zinkernagel RM & Hengartner H. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells. Eur J Immunol 1998; 28: 3301-3311.
56. Sher A. Strategies for vaccination against parasites. In The Biology of Parasitism, eds Englund PT, Sher A. New York: Alan R. Liss; 1988: 169-172.
57. Schetters TPM & Montenegro-James S. Vaccines against babesiosis using soluble parasite antigens. Parasitol Today 1995; 11: 456-462.
58. Tripp CL, Wagner GG & Rice-Ficht AC. Babesia bovis: gene isolation and characterization using a mung bean nuclease-derived expression library. Exp Parasitol 1989; 69: 211-225.
59. Hines SA, Palmer GH, Brown WC et al. Genetic and antigenic characterization of Babesia bovis merozoite spherical body protein Bb-1. Mol Biochem Parasitol 1995; 69: 149-159.
60. Goodger BV, Waltisbuhl DJ, Commins MA & Wright IG. Babesia bovis: dextran sulphate as an adjuvant for and precipitant of protective immunogens. Int J Parasitol 1992; 22: 465-469.
61. Suarez CE, Palmer GH, Jasmer DP, Hines SA, Perryman LE & McElwain TF. Characterization of a gene encoding a 60-kilodalton Babesia bovis merozoite protein with conserved and surface exposed epitopes. Mol Biochem Parasitol 1991; 46: 45-52.
62. Harper GS, Hibbs AR, East IJ, Waltisbuhl DJ, Jorgensen WK & Riddles PW. Babesia bovis: biosynthesis and localisation of 12D3 antigen in bovine erythrocytes. Int J Parasitol 1996; 26: 1255-1262.
63. Court RA, Sitte K, Opdebeed JP & East IJ. Mapping T cell epitopes of the Babesia bovis antigen 12D3: implications for vaccine design. Parasite Immunol 1998; 20: 1-8.
64. Valentin A, Precigout E, L'Hostis M, Carcy B, Gorenflot A & Schrevel J. Cellular and humoral responses induced in cattle by vaccination with Babesia divergens culture-derived exoantigens correlate with protection. Infect Immun 1993; 61: 734-741.
65. Carcy B, Precigout E, Valentin A, Gorenflot A & Schrevel J. A 37-kilodalton glycoprotein of Babesia divergens is a major component of a protective fraction containing low-molecular-mass culture-derived exoantigens. Infect Immun 1995; 63: 811-817.
66. Precigout E, Delbecq S, Vallet A et al. Associations between sequence polymorphism in an epitope of Babesia divergens Bd37 exoantigen and protection induced by passive transfer. Int J Parasitol 2004; 34: 585-593.
67. Delbecq S, Hadj-Kaddour K, Randazzo S et al. Hydrophobic moieties in recombinant proteins are crucial to generate efficient saponin-based vaccine against apicomplexan Babesia divergens. Vaccine 2006; 24: 613-621.
68. McElwain TF, Palmer GH, Goff WL & McGuire TC. Identification of Babesia bigemina and Babesia bovis merozoite proteins with isolate- and species-common epitopes recognized by antibodies in bovine immune sera. Infect Immun 1988; 56: 1658-1660.
69. Goff WL, Davis WC, Palmer GH et al. Identification of Babesia bovis merozoite surface antigens by using immune bovine sera and monoclonal antibodies. Infect Immun 1988; 56: 2363-2368.
70. Jasmer DP, Reduker DW, Hines SA, Perryman LE & McGuire TC. Surface epitope localization and gene structure of a Babesia bovis 44-kilodalton variable merozoite surface antigen. Mol Biochem Parasitol 1992; 55: 75-84.
71. Brown WC, Logan KS, Wagner GG & Tetzlaff CL. Cell-mediated immune responses to Babesia bovis antigens in cattle following infection with tick-derived or cultured parasites. Infect Immun 1991; 59: 2418-2426.
72. Hines SA, Palmer GH, Jasmer DP, McGuire TC & McElwain TF. Neutralization-sensitive merozoite surface antigens of Babesia bovis encoded by members of a polymorphic gene family. Mol Biochem Parasitol 1992; 55: 85-94.
73. Hines SA, Palmer GH, Jasmer DP, Goff WL & McElwain TF. Immunization of cattle with recombinant Babesia bovis merozoite surface antigen-1. Infect Immun 1995; 63: 349-352.
74. Suarez CE, Florin-Christensen M, Hines SA, Palmer GH, Brown WC & McElwain TF. Characterization of allelic variation in the Babesia bovis merozoite surface antigen-1 (msa-1) locus and identification of a cross-reactive, inhibition-sensitive MSA-1 epitope. Infect Immun 2000; 68: 6865-6870.
75. Mosqueda J, McElwain TF & Palmer GH. Babesia bovis merozoite surface antigen 2 proteins are expressed on the merozoite and sporozoite surface, and specific antibodies inhibit attachment and invasion of erythrocytes. Infect Immun 2002; 70: 6448-6455.
76. LeRoith T, Brayton KA, Molloy JB et al. Sequence variation and immunologic cross-reactivity among Babesia bovis merozoite surface antigen 1 proteins from vaccine strains and vaccine breakthrough isolates. Infect Immun 2005; 73: 5388-5394.
77. Florin-Christensen M, Suarez CE, Hines SA, Palmer GH, Brown WC & McElwain TF. The Babesia bovis merozoite surface antigen 2 locus contains four tandemly arranged and expressed genes encoding immunologically distinct proteins. Infect Immun 2002; 70: 3566-3575.
78. Berens SJ, Brayton KA, Molloy JB, Bock RE, Lew AE & McElwain TF. Merozoite surface antigen 2 proteins of Babesia bovis vaccine breakthrough isolates contain a unique hypervariable region composed of degenerate repeats. Infect Immun 2005; 73: 7180-7189.
79. Willowsky SE, Farber M, Echiade I et al. Babesia bovis merozoite surface protein-2c (MSA-2c) contains highly immunogenic, conserved B-cell epitopes that elicit neutralization-sensitive antibodies in cattle. Mol Biochem Parasitol 2003; 127: 133-141.
80. LeRoith T, Berens S, Brayton KA et al. The Babesia bovis merozoite surface antigen 1 hypervariable region induces surface-reactive antibodies that block invasion. Infect Immun 2006; 74: in press.
81. Gazzinelli RT, Ropert C & Campos MA. Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites. Immunol Rev 2004; 201: 9-25.
82. Jasmer DP, Reduker DW, Perryman LE & McGuire TC. A Babesia bovis 225-kilodalton protein located on the cytoplasmic side of the erythrocyte membrane has sequence similarity with a region of glycogen phosphorylase. Mol Biochem Parasitol 1992; 52: 263-269.
83. Dowling SC, Perryman LE & Jasmer DP. A Babesia bovis 225-kilodalton spherical body protein: localization to the cytoplasmic face of infected erythrocytes after merozoite invasion. Infect Immun 1996; 64: 2618-2626.
84. Ruef BJ, Dowling SC, Conley PG et al. A unique Babesia bovis spherical body protein is conserved among geographic isolates and localizes to the infected erythrocyte membrane. Mol Biochem Parasitol 2000; 105: 1-12.
85. McElwain TF, Perryman LE, Musoke AJ & McGuire TC. Molecular characterization and immunogenicity of neutralization-sensitive Babesia bigemina merozoite surface proteins. Mol Biochem Parasitol 1991; 47: 213-222.
86. Suarez CE, Palmer GH, Hötzel I & McElwain TF. Structure, sequence, and transcriptional analysis of the Babesia bovis rap-1 multigene locus. Mol Biochem Parasitol 1998; 93: 215-224.
87. Suarez CE, Palmer GH, Florin-Christensen M, Hines SA, Hötzel I & McElwain TF. Organization, transcription, and expression of rhoptry associated protein genes in the Babesia bigemina rap-1 locus. Mol Biochem Parasitol 2003; 127: 101-112.
88. Brown WC, McElwain TF, Hötzel I, Suarez CE & Palmer GH. Helper T cell epitopes encoded by the Babesia bigemina rap-1 gene family in the constant and variant domains are conserved among parasite strains. Infect Immun 1998; 66: 1561-1569.
89. Fisher TG, McElwain TF & Palmer GH. Molecular basis for variable expression of merozoite surface antigen gp45 among American isolates of Babesia bigemina. Infect Immun 2001; 69: 3782-3790.
90. O'Connor RM & Allred DR. Selection of Babesia bovis-infected erythrocytes for adhesion to endothelial cells co-selects for altered variant erythrocyte surface antigen isoforms. J Immunol 2000; 164: 2037-2045.
91. Estes DM & Brown WC. The type 1/type 2 paradigm and regulation of humoral immune responses in cattle. Vet Immunol Immunopathol 2002; 90: 1-10.
92. Brown WC, Logan KS, Zhao S, Bergman DK & Rice-Ficht AC. Identification of Babesia bovis merozoite antigens separated by continuous-flow electrophoresis that stimulate proliferation of helper T cell clones derived from B. bovis-immune cattle. Infect Immun 1995; 63: 3106-3116.
93. + T cell lines from genetically diverse cattle. Exp Parasitol 1999; 91: 40-51.
94. Ruef BJ, Ward TJ, Oxner CR, Conley PG, Brown WC & Rice-Ficht AC. Phylogenetic analysis with newly characterized Babesia bovis hsp70 and hsp90 provides strong support for paraphyly with the piroplasms. Mol Biochem Parasitol 2000; 109: 67-72.
95. + T lymphocyte responses in B. bovis-immune cattle. Mol Biochem Parasitol 2001; 118: 97-109.
96. Lee S, Carson K, Rice-Ficht A & Good T. Hsp20, a novel α-crystallin, prevents Aβ fibril formation and toxicity. Prot Sci 2005; 14: 593-601.
97. + T lymphocyte responses in B. bovis-immune cattle. Mol Biochem Parasitol 2006; 147: 20-29.
98. Santos C & Ballesta JPG. Ribosomal protein P0, contrary to phosphoproteins P1 and P2, is required for ribosome activity and Saccharomyces cerevisiae viability. J Biol Chem 1994; 269: 15689-15696.
99. Brown WC, McElwain TF, Ruef BJ et al. Babesia bovis rhoptry-associated protein-1 is immunodominant for T helper cells of immune cattle and contains T cell epitopes conserved among geographically distant B. bovis strains. Infect Immun 1996; 64: 3341-3350.
100. Ruef BJ, Tuo W, Rodriguez SD et al. Immunization with Babesia bigemina rhoptry-associated protein 1 induces a type 1 cytokine response. Journal of Interferon and Cytokine Research. J Interferon Cytokine Res 1997; 17: 45-54.
101. + T lymphocyte responses in B. bovis-immune individuals are located in the amino terminal domain. Infect Immun 2002; 70: 2039-2048.
102. Norimine J, Mosqueda J, Suarez C et al. Stimulation of T helper cell IFN-gamma and IgG responses specific for Babesia bovis rhoptry associated protein 1 (RAP-1) or a RAP-1 protein lacking the carboxy terminal repeat region is insufficient to provide protective immunity against virulent B. bovis challenge. Infect Immun 2003; 71: 5021-5032.
103. Brown WC, Palmer GH, McElwain TF, Hines SA & Dobbelaere DAE. Babesia bovis: Characterization of the T helper cell response against the 42 kilodalton merozoite surface antigen (MSA-1) in cattle. Exp Parasitol 1993; 77: 97-110.
104. Tetzlaff CL, Rice-Ficht AC, Woods VM & Brown WC. Induction of proliferative responses in T-cells from Babesia bovis immune cattle with a recombinant 77 kDa merozoite protein (Bb-1). Infect Immun 1992; 60: 644-652.
105. Brown WC, Zhao S, Woods V et al. Identification of two Th1 cell epitopes on the 77 kDa Babesia bovis merozoite protein (Bb-1) by use of truncated recombinant fusion proteins. Infect Immun 1993; 61: 236-244.
106. Norimine J, Mosqueda J, Palmer GH, Lewin HA & Brown WC. Conservation of Babesia bovis small heat shock protein (Hsp20) among strains and definition of T helper cell epitopes recognized by cattle with diverse major histocompatibility class II haplotypes. Infect Immun 2004; 72: 1096-1106.
107. Mosqueda J, McElwain TF, Stiller D & Palmer GH. Babesia bovis merozoite surface antigen 1 and rhoptry-associated protein 1 are expressed in sporozoites, and specific antibodies inhibit sporozoite attachment to erythrocytes. Infect Immun 2002; 70: 1599-1603.
108. Yokoyama N, Suthisak B, Hirata H et al. Cellular localization of Babesia bovis merozoite rhoptry-associated protein 1 and its erythrocyte-binding activity. Infect Immun 2002; 70: 5822-5826.
109. Gaffar FR, Yatsuda AP, Franssen FF & de Vries E. Erythrocyte invasion by Babesia bovis merozoites is inhibited by polyclonal antisera directed against peptides derived from a homologue of Plasmodium falciparum apical membrane antigen 1. Infect Immun 2004; 72: 2947-2955.
110. Gaffar FR, Yatsuda AP, Frannsen FF & de Vries E. A Babesia bovis merozoite protein with a domain architecture highly similar to the thrombospondin-related anonymous protein (TRAP) present in Plasmodium sporozoites. Mol Biochem Parasitol 2004; 136: 25-34.
111. Howell S, Withers-Martinez C, Kocken CH, Thomas AW & Blackman MJ. Proteolytic procession and primary structure of Plasmodium falciparum apical membrane antigen-1. J Biol Chem 2001; 276: 31311-31320.
112. Howell SA, Well I, Fleck SL, Kettleborough C, Collins CR & Blackman MJ. A single malaria merozoite serine protease mediates shedding of multiple surface proteins by juxtamembrane cleavage. J Biol Chem 2003; 278: 23890-23898.
113. Anders RF, Crewther PE, Edwards S et al. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine 1998; 16: 240-247.
114. Kocken CH, Narum DL, Massougbodji A et al. Molecular characterization of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with Plasmodium falciparum AMA-1, and antibody-mediated inhibition of red cell invasion. Mol Biochem Parasitol 2000; 109: 147-156.
115. Kocken CH, Withers-Martinez C, Dubbeld MA et al. High-level expression of the malaria vaccine candidate Plasmodium falciparum apical membrane antigen 1 and the induction of antibodies that inhibit erythrocyte invasion. Infect Immun 2002; 70: 4471-4476.
116. Sultan AA, Thathy V, Frevert U et al. TRAP is necessary for gliding motility and infectivity of Plasmodium sporozoites. Cell 1997; 90: 511-522.
117. Riding G, Hope M, Waltisbuhl D & Willadsen P. Identification of novel protective antigens from Anaplasma marginale. Vaccine 2003; 21: 1874-1883.
118. Lopez JE, Siems WF, Brayton KA, Palmer GH, McGuire TC & Brown WC. Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping. Infect Immun 2005; 73: 8109-8118.
119. Klenerman P, Cerundolo V & Dunbar PR. Tracking T cells with tetramers: new tales from new tools. Nat Rev Immunol 2002; 2: 263-272.
120. Mallone R & Nepom GT. MHC class II tetramers and the pursuit of antigen-specific T cells: define, deviate, delete. Clin Immunol 2004; 110: 232-242.